Award notice Supplies

Époétine alfa

Notice published in French. The AI analysis summarises it for you in your language.

Official notice and documents

Public buyer: CHIREC
Bruxelles (Auderghem)
Place of performance: 1160 Bruxelles (Auderghem), Brussels-Capital
Amount awarded: €303,318 excl. VAT
Planned end of contract: 31 March 2029
likely re-tender around October 2028
Bids received: 1
Procedure: Open procedure
Any company may submit a bid.
Publication: 1 April 2025
Notice language: French

AI analysis: go for it or not?

Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.

Create my free account

Unlimited analyses during the 14-day Pro trial, no card needed.

Description

Époétine alfa

Awarded to

Sandoz BCE/KBO 0457.517.227

CPV codes

European codes that classify what the contract is about. They are how we find the tenders for your trade.

33600000

Winning prices for comparable contracts

A quarter below: €269,390
Median: €449,863
A quarter above: €962,736

Amounts awarded (excl. VAT) over the last 3 years for 58 contracts in the same CPV group (3360…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.

Similar contracts already awarded

Contract	Winner	Amount
Fer injectable CHIREC · 7 October 2026	Viatris	€432,640
Antitumoraux per os CHIREC · 16 October 2025	EG Grindeks Kalceks Belgium	€120,203
Ranibizumab CHIREC · 17 January 2025	Teva Pharma Belgium	€571,200
Facteurs de stimulation des colonies de granulocytes (G-CSF) CHIREC · 17 December 2024	Teva Pharma Belgium ACCORD HEALTHCARE	€277,997
Antitumoraux CHIREC · 17 December 2024	ACCORD HEALTHCARE AUROBINDO Fresenius Kabi Arega Pharma	€977,080

Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 207780-2025.